Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2018

Feb 22, 2018

29777_dirs_2018-02-21_9843a613-b9d1-4056-af4a-52e0f3e73ebb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-02-16

Reporting Person: Fussell Stephen R (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-16 Common shares without par value A 44909 Acquired 184884 Direct
2018-02-20 Common shares without par value M 104642 $38.40 Acquired 289526 Direct
2018-02-20 Common shares without par value S 1100 $59.47 Disposed 288426 Direct
2018-02-20 Common shares without par value S 300 $59.48 Disposed 288126 Direct
2018-02-20 Common shares without par value S 1419 $59.49 Disposed 286707 Direct
2018-02-20 Common shares without par value S 441 $59.495 Disposed 286266 Direct
2018-02-20 Common shares without par value S 1200 $59.50 Disposed 285066 Direct
2018-02-20 Common shares without par value S 1172 $59.51 Disposed 283894 Direct
2018-02-20 Common shares without par value S 200 $59.515 Disposed 283694 Direct
2018-02-20 Common shares without par value S 728 $59.52 Disposed 282966 Direct
2018-02-20 Common shares without par value S 989 $59.53 Disposed 281977 Direct
2018-02-20 Common shares without par value S 226 $59.54 Disposed 281751 Direct
2018-02-20 Common shares without par value S 574 $59.545 Disposed 281177 Direct
2018-02-20 Common shares without par value S 180 $59.56 Disposed 280997 Direct
2018-02-20 Common shares without par value S 500 $59.58 Disposed 280497 Direct
2018-02-20 Common shares without par value S 500 $59.585 Disposed 279997 Direct
2018-02-20 Common shares without par value S 500 $59.59 Disposed 279497 Direct
2018-02-20 Common shares without par value S 100 $59.595 Disposed 279397 Direct
2018-02-20 Common shares without par value S 22500 $59.60 Disposed 256897 Direct
2018-02-20 Common shares without par value S 1600 $59.63 Disposed 255297 Direct
2018-02-20 Common shares without par value S 500 $59.635 Disposed 254797 Direct
2018-02-20 Common shares without par value S 1700 $59.64 Disposed 253097 Direct
2018-02-20 Common shares without par value S 600 $59.645 Disposed 252497 Direct
2018-02-20 Common shares without par value S 4794 $59.65 Disposed 247703 Direct
2018-02-20 Common shares without par value S 3200 $59.655 Disposed 244503 Direct
2018-02-20 Common shares without par value S 10 $59.6575 Disposed 244493 Direct
2018-02-20 Common shares without par value S 8206 $59.66 Disposed 236287 Direct
2018-02-20 Common shares without par value S 2985 $59.665 Disposed 233302 Direct
2018-02-20 Common shares without par value S 77 $59.668 Disposed 233225 Direct
2018-02-20 Common shares without par value S 100 $59.669 Disposed 233125 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-16 Option (right to buy) $59.94 A 246963 Acquired 2028-02-15 Common shares (246963) Direct
2018-02-20 Option (right to buy) $38.40 M 104642 Disposed 2026-02-18 Common shares (104642) Direct

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.